Meaningful Use 3

For 2018, NHSN Antimicrobial Use (AU) and Antimicrobial Resistance (AR) (AUR) reporting have been identified as a new option for public health registry reporting under Meaningful Use Stage 3 (MU3).

Refer to the certification criterion (§ 170.315(f)(6)) in the Medicare and Medicaid Programs; Electronic Health Record Incentive Program-Stage 3 and Modifications to Meaningful Use in 2015 Through 2017External.

Beginning January 2017, a facility enrolled in the National Healthcare Safety Network (NHSN) has the option to register their intent to satisfy the AUR-MU3 objective.

 Top of Page

AUR-MU3 Guidance

 Top of Page

AUR-MU3 Validation Tool

In order to qualify as certified technology, an Electronic Health Record (EHR) or EHR Module must be capable of creating Clinical Document Architecture (CDA) documents for Antimicrobial Use and Resistance conformant to the HL7 Implementation Guide for CDA ® Release 2—Level 3: Healthcare Associated Infection Reports, Release 1—US Realm—August 2013External. (To download an Implementation Guide, you are required to login to the HL7 site.)

The following CDAs must all be successfully generated.

  • Antimicrobial Resistance Option (ARO) Report (Numerator) specific document template in Section 2.1.2.1 (pages 69-72)
  • Antimicrobial Resistance Option (ARO) Summary Report (Denominator) specific document template in Section 2.1.1.1 (pages 54-56)
  • Antimicrobial Use (AUP) Summary Report (Numerator and Denominator) specific document template in Section 2.1.1.2 (pages 56-58)

You may self-validate your files prior to sending them to the ONC Health IT Certification Program. View installation instructions for the NHSN AUR MU3 Validation ToolExternal.

 Top of Page

ONC Certification

To certify your Health IT Module in the ONC Health IT Certification Program for NHSN Antimicrobial Use and Resistance reporting, contact ICSA Labs (ehr@icsalabs.com)

Learn more about Meaningful Use Incentives and CertificationExternal.

 Top of Page